Great Chemistry Cures
At Enanta, we are committed to creating important, novel medicines by pursuing bold ideas, employing rigorous research, and striving for scientific excellence in everything we do. We are fortunate to have some of the best and brightest minds across pharma and biotech working at Enanta. We are passionate about science and dedicated to discovering and developing highly differentiated therapeutics through innovative chemistry to treat diseases in areas of high unmet need. These efforts have resulted in developing drugs for combination regimens that have cured more than one million people with chronic hepatitis C virus infection. It’s incredibly rewarding for our scientific expertise to have such an impact on patients’ lives, and this drives us to do it again in other disease areas.
Enanta’s heritage is steeped in scientific expertise and a track record of effective innovation. Without either, we wouldn’t be where we are today. We are dedicated to applying these capabilities and experience each day in hopes of improving patients’ lives. We’ve done it before, and we’re determined to do it again.
February 7, 2024
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
February 6, 2024
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023